Table 1.
Characteristics of the study participants.
| Total N | 139 | ||
|---|---|---|---|
| Sex | |||
| Female | 90 | 64.7% | |
| Race | |||
| Asian | 31 | 22.3% | |
| African American | 4 | 2.9% | |
| White | 88 | 63.3% | |
| Other/Multiple | 16 | 11.5% | |
| Ethnicity | |||
| Latinx | 15 | 10.8% | |
| Age | |||
| Median (IQR) | 36 | 27–61 | |
| Provider Type | |||
| ED Nurse | 64 | 46.0% | |
| Attending Physician | 31 | 22.3% | |
| Resident Physician | 23 | 16.5% | |
| Advanced Practice Provider | 7 | 5.0% | |
| Emergency Medical Technician | 9 | 6.5% | |
| Other | 5 | 3.6% | |
| Prior History of COVID-19 infection at baseline | |||
| Yes | 5 | 3.6% | |
| Follow-Up COVID-19 infection at 3 months | 135 | ||
| Incident Cases | 1 | 0.8% | |
| Follow-up COVID-19 infection at 6 months | 134 | ||
| Incident Cases | 0 | 0% | |
| COVID-19 Vaccination Status | |||
| Received vaccination | 138 | 99.3% | |
| Vaccine manufacturer | |||
| Pfizer | 130 | 94.2% | |
| Moderna | 8 | 5.8% | |
| Time between 2nd dose and 6 mo. visit (weeks) | |||
| Median (IQR) | 9.9 | 8.7–11.3 |